NCT06629584 2026-02-17
Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia
M.D. Anderson Cancer Center
Phase 2 Recruiting
Clinical Trials
7 trialsNCT02421380 2025-11-06
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT05579275 2024-05-14
Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors
Peking University Cancer Hospital & Institute
Phase EARLY_PHASE1 Recruiting
NCT05930457 2023-12-26
Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors
The First Affiliated Hospital of Guangzhou Medical University
Phase 1 Completed
NCT05814835 2023-12-20
First in Human Study of 68Ga/64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors
Chinese PLA General Hospital
Phase 1 Completed
NCT06082557 2023-10-13
A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2 Unknown
NCT01694472 2015-12-22
Clinical Safety and Preliminary Efficacy of MAGE-A4 TCR Gene-Modified T Cells to Treat Malignant Tumors
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Unknown